Emergent BioSolutions’ ACAM2000 receives FDA approval for Mpox prevention
Emergent BioSolutions Inc. (NYSE: EBS) has achieved a notable milestone with the U.S. Food and Drug Administration (FDA) approving the supplemental Biologics License Application (sBLA) ... Read More
Sequent Scientific secures WHO prequalification for Albendazole API
Sequent Scientific Limited, a leading Indian pharmaceutical company, has achieved a significant milestone by securing prequalification (PQ) approval from the World Health Organization (WHO) for ... Read More
USAID awards $236m contract to ICF for global health surveys
ICF (NASDAQ: ICFI), a global consulting and technology services provider, has been awarded a five-year, $236 million contract by the U.S. Agency for International Development ... Read More
Dr. Reddy’s Laboratories launches migraine management wearable Nerivio in Germany
In an exciting development for migraine sufferers, Dr. Reddy’s Laboratories Ltd., a leader in the global pharmaceutical industry, has announced the launch of its groundbreaking, ... Read More
lpca Laboratories and Omexa Formulary join forces to develop anti-cancer biosimilar
lpca Laboratories Ltd. (lpca) has embarked on a collaboration with Omexa Formulary Pvt. Ltd. (Omexa), through a Technology Transfer Agreement aimed at fostering the development ... Read More
UAE grants emergency use authorization for Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) has granted emergency use authorization for the Sputnik ... Read More
WHO announces first malaria vaccine trials in Ghana, Kenya, and Malawi
The World Health Organization (WHO) has announced a pivotal step in global health: the initiation of the world's first malaria vaccine trials in Ghana, Kenya, ... Read More
Dengvaxia : Sanofi Pasteur rolls out world’s first dengue vaccine in Guatemala
Sanofi Pasteur, the French pharmaceutical giant, has announced the rollout of Dengvaxia, the world's first dengue vaccine, in Guatemala in the upcoming days. This significant ... Read More
Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism
Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug Parsabiv (etelcalcetide) by the European Commission (EC) ... Read More
Sun Pharma collaborates with ICGEB to develop affordable dengue vaccine
Sun Pharma, an Indian multinational pharmaceutical company, has announced a collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new ... Read More